Ad TechIndustry TrendMay 11, 2026
Pharma’s CTV push is stalled by weak measurement tools
The article discusses how pharmaceutical advertisers are increasingly interested in connected television (CTV), but their adoption is hindered by the lack of robust measurement solutions for the platform.
Key Takeaways
- Pharmaceutical advertisers have been watching connected television from the sidelines for years.
- The article identifies measurement as the missing link for pharma brands embracing CTV.
- The core barrier is the lack of robust measurement solutions for the platform.
Why It Matters
Pharma interest in CTV is no longer the question; measurement is. The article frames weak measurement as the practical barrier keeping pharmaceutical advertisers on the sidelines, even as other industries have already moved into the channel. For the CTV ecosystem, that puts pressure on ad tech and measurement vendors to prove the platform can support a category that cares about accountability. The next signal to watch is whether the article’s measurement gap gets addressed by new CTV measurement offerings aimed at pharma buyers.
Read full article at beet.tv